Ikoma, Japan

Noriko Ishizaka



Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Noriko Ishizaka: Pioneering Innovations in Pharmaceutical Chemistry

Introduction

Noriko Ishizaka, based in Ikoma, Japan, is an accomplished inventor with a focus on pharmaceutical chemistry. With a total of 2 patents, she has made significant strides in the development of compounds aimed at treating various diseases. Her innovative work addresses critical health challenges and underscores the importance of research in medicinal chemistry.

Latest Patents

One of Ishizaka's notable patents is for an Indole derivative having IκB kinase β inhibitory activity. This invention discloses a compound represented by a general formula that showcases an inhibitory activity on IKKβ, making it potentially useful as a preventive and therapeutic agent for diseases associated with this kinase. The patent outlines how certain groups within the compound can vary, thereby enhancing its applicability in medical contexts.

Another significant patent by Ishizaka is a Pyrrole derivative having ureido group and aminocarbonyl group as substituents. The objective of this invention is to synthesize a novel pyrrole derivative and explore its pharmacological effects, particularly its potential as a medicinal agent for retinal diseases. This compound exhibits inhibitory activity against the production of interleukin-6 and presents promising therapeutic applications for ocular inflammatory diseases and retinal disorders.

Career Highlights

Noriko Ishizaka is associated with Santen Pharmaceutical Co., Ltd., where her research and innovative efforts contribute to advancing pharmaceutical developments. Her focus on potent compounds illustrates her dedication to improving healthcare outcomes.

Collaborations

Throughout her career, Ishizaka has collaborated with accomplished colleagues such as Hiroshi Enomoto and Kenji Kawashima. These partnerships in research foster a dynamic environment for innovation, enabling the discovery of impactful medicinal compounds.

Conclusion

In conclusion, Noriko Ishizaka stands out as a key figure in pharmaceutical innovation. Her patents not only reflect her expertise but also her commitment to addressing significant health challenges through scientific research. With continued collaboration and innovation, Ishizaka is likely to contribute even more to the field of pharmaceutical chemistry in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…